Orogen Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $18.2M

  • Investors
  • 2

Orogen Therapeutics General Information

Description

Operator of a biotechnology research firm intended to develop novel drugs for autoimmune diseases. The company specializes in designing novel therapeutics using proprietary DNA-encoded libraries screening technology and artificial intelligence small molecule discovery, enabling doctors to treat patients with serious unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Gill Street
  • Suite 4200
  • Woburn, MA 01801
  • United States
Primary Industry
Drug Discovery
Corporate Office
  • 12 Gill Street
  • Suite 4200
  • Woburn, MA 01801
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orogen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 16-Jun-2023 $18.2M Completed Startup
To view Orogen Therapeutics’s complete valuation and funding history, request access »

Orogen Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Orogen Therapeutics’s complete cap table history, request access »

Orogen Therapeutics Patents

Orogen Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026231857-A1 Focused dna-encoded libraries and methods of use thereof Pending 29-Apr-2025

Orogen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orogen Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anterra Capital Venture Capital Minority
Novalis LifeSciences Venture Capital Minority
To view Orogen Therapeutics’s complete investors history, request access »

Orogen Therapeutics FAQs

  • When was Orogen Therapeutics founded?

    Orogen Therapeutics was founded in 2023.

  • Where is Orogen Therapeutics headquartered?

    Orogen Therapeutics is headquartered in Woburn, MA.

  • What is the size of Orogen Therapeutics?

    Orogen Therapeutics has 19 total employees.

  • What industry is Orogen Therapeutics in?

    Orogen Therapeutics’s primary industry is Drug Discovery.

  • Is Orogen Therapeutics a private or public company?

    Orogen Therapeutics is a Private company.

  • What is the current valuation of Orogen Therapeutics?

    The current valuation of Orogen Therapeutics is .

  • What is Orogen Therapeutics’s current revenue?

    The current revenue for Orogen Therapeutics is .

  • How much funding has Orogen Therapeutics raised over time?

    Orogen Therapeutics has raised $18.2M.

  • Who are Orogen Therapeutics’s investors?

    Anterra Capital and Novalis LifeSciences have invested in Orogen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process